Surmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company's Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices; international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device. The Company's In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. The In Vitro Diagnostics segment manufactures and sells surface coatings to the diagnostic, biomedical research and life science markets. In Vitro Diagnostics segment offers protein stabilization reagents, substrates, antigens and surface coatings.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Diagnostic Substances
- Sub-Industry: Health Care Equipment
- Exchange: NASDAQ
- Symbol: SRDX
- CUSIP: 86887310
- Previous Close: $25.05
- 50 Day Moving Average: $24.64
- 200 Day Moving Average: $26.58
- 52-Week Range: $17.45 - $30.75
- Trailing P/E Ratio: 34.32
- Foreward P/E Ratio: 36.30
- P/E Growth: 5.20
- Market Cap: $332.31M
- Outstanding Shares: 13,266,000
- Beta: 1.03
- Net Margins: 13.46%
- Return on Equity: 13.14%
- Return on Assets: 10.69%
Companies Related to SurModics:
- Current Ratio: 9.55%
- Quick Ratio: 8.97%
What is SurModics' stock symbol?
SurModics trades on the NASDAQ under the ticker symbol "SRDX."
Where is SurModics' stock going? Where will SurModics' stock price be in 2017?
2 equities research analysts have issued 12 month price objectives for SurModics' shares. Their predictions range from $30.00 to $33.00. On average, they anticipate SurModics' share price to reach $31.50 in the next twelve months.
When will SurModics announce their earnings?
SurModics is scheduled to release their next quarterly earnings announcement on Monday, May, 1st 2017.
Who owns SurModics stock?
SurModics' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (7.27%), Dimensional Fund Advisors LP (4.45%), Royce & Associates LP (2.48%), State Street Corp (2.37%), Teton Advisors Inc. (2.10%) and Numeric Investors LLC (1.74%). Company insiders that own SurModics stock include Bryan K Phillips, Charles W Olson, Gary R Maharaj, Joseph J Stich, Susan E Knight and Timothy J Arens.
Who sold SurModics stock? Who is selling SurModics stock?
SurModics' stock was sold by a variety of institutional investors in the last quarter, including GSA Capital Partners LLP, Guggenheim Capital LLC, Oxford Asset Management, Numeric Investors LLC, Cadence Capital Management LLC, AQR Capital Management LLC, Metropolitan Life Insurance Co. NY and Allianz Asset Management AG. Company insiders that have sold SurModics stock in the last year include Bryan K Phillips, Charles W Olson, Gary R Maharaj, Joseph J Stich, Susan E Knight and Timothy J Arens.
Who bought SurModics stock? Who is buying SurModics stock?
SurModics' stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Dimensional Fund Advisors LP, Russell Investments Group Ltd., State Street Corp, Disciplined Growth Investors Inc. MN, Systematic Financial Management LP, Two Sigma Investments LP and O Shaughnessy Asset Management LLC.
How do I buy SurModics stock?
Shares of SurModics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of SurModics stock cost?
One share of SurModics stock can currently be purchased for approximately $25.05.